Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.

Journal of thrombosis and haemostasis : JTH - 1 Sept 2005

De Stefano V, Sorà F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G

Abstract excerpt

BACKGROUND: Thromboembolism can occur during acute leukemia, especially acute lymphoid leukemia (ALL) treated with L-asparaginase. Yet, most reports are anecdotical and scarce data are available on the risk of thrombosis in acute myeloid leukemia (AML). OBJECTIVES: To evaluate the risk of thrombosis in patients with acute leukemia. PATIENTS AND METHODS: Three-hundred and seventy-nine consecutive adult patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Adolescent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asparaginase

Share to Follow-Up Studies

Share to Incidence

Share to Leukemia

Share to Thrombosis

Source

Identifiers

PMID: 16102104
DOI: 10.1111/j.1538-7836.2005.01467.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.PMID 16102104Read ↗

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.Semantic proximity Read ↗

Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.Semantic proximity Read ↗

Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.Semantic proximity Read ↗

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia.Semantic proximity Read ↗

The risk factors for thrombosis in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.Semantic proximity Read ↗

Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.Semantic proximity Read ↗

Analysis of early death in newly diagnosed acute promyelocytic leukemia patientsSemantic proximity Read ↗

Thrombosis in children with acute lymphoblastic leukemia Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment.Semantic proximity Read ↗

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

2 Cases of Pegylated Asparaginase-Associated Cerebral Venous Sinus Thrombosis in Children: Clinical Analysis and Literature ReviewSemantic proximity Read ↗

Risk factors of thrombosis in chinese subjects with acute promyelocytic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.